# EDGAR Filing Document

**Accession Number:** 0000915389
**File Stem:** 0000915389-26-000006
**Filing Date:** 2026-1
**Character Count:** 59304
**Document Hash:** 56d8b3dedffea8e16eac6e3ad12a9749
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000915389-26-000006.hdr.sgml**: 20260129

**ACCESSION NUMBER**: 0000915389-26-000006

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 16

**CONFORMED PERIOD OF REPORT**: 20260129

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260129

**DATE AS OF CHANGE**: 20260129

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** EASTMAN CHEMICAL CO
- **CENTRAL INDEX KEY:** 0000915389
- **STANDARD INDUSTRIAL CLASSIFICATION:** PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 621539359
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-12626
- **FILM NUMBER:** 26578168

**BUSINESS ADDRESS:**
- **STREET 1:** PO BOX 511
- **STREET 2:** 200 SOUTH WILCOX DRIVE
- **CITY:** KINGSPORT
- **STATE:** TN
- **ZIP:** 37660
- **BUSINESS PHONE:** 4232292000

**MAIL ADDRESS:**
- **STREET 1:** P O BOX 511 B-54D
- **CITY:** KINGSPORT
- **STATE:** TN
- **ZIP:** 37662

?xml version='1.0' encoding='ASCII'? emn-20260129

![Eastman_Black_300dpi.jpg](emn-20260129_g1.jpg)

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934**

**Date of report (Date of earliest event reported):**

**January 29, 2026**

**EASTMAN CHEMICAL COMPANY** 

(Exact Name of Registrant as Specified in Its Charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **1-12626** | **62-1539359** |
| (State or Other Jurisdiction<br>of Incorporation) | (Commission File Number) | (IRS Employer<br>Identification No.) |

---

---

| | | |
|:---|:---|:---|
| **200 South Wilcox Drive** | **200 South Wilcox Drive** | |
| **Kingsport** | **Tennessee** | **37662** |
| (Address of Principal Executive Offices) | (Address of Principal Executive Offices) | (Zip Code) |

---

**(423) 229-2000** 

(Registrant's Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| **Common Stock, par value $0.01 per share** | **EMN** | **New York Stock Exchange** |
| **1.875% Notes Due 2026** | **EMN26** | **New York Stock Exchange** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

EASTMAN CHEMICAL COMPANY - EMN

**Item 2.02 Results of Operations and Financial Condition**

On January 29, 2026, the registrant publicly released its financial results for fourth quarter 2025. The full text of the release is furnished as <u>[Exhibit 99.01](ex99_0120251231cctables.htm)</u> to this Current Report on Form 8-K, and is incorporated herein by reference. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

**Item 9.01 Financial Statements and Exhibits:**

(d) Exhibits

The following exhibits are furnished pursuant to Item 9.01:

<u>[99.01](ex99_0120251231cctables.htm)</u>&nbsp;&nbsp;&nbsp;&nbsp;Public release by Eastman on January 29, 2026 of fourth quarter 2025 financial results

104&nbsp;&nbsp;&nbsp;&nbsp;Cover Page Interactive Data File

------

EASTMAN CHEMICAL COMPANY - EMN

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

---

| | |
|:---|:---|
| | Eastman Chemical Company  |
| By: | /s/ Michelle R. Stewart |
|  | Michelle R. Stewart |
|  | Vice President, Chief Accounting Officer and Corporate Controller |
|  | Date: January 29, 2026 |

---

## Exhibit 99.01

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**Exhibit 99.01**

**Eastman Announces Fourth-Quarter and Full-Year 2025 Financial Results**

KINGSPORT, Tenn., January 29, 2026 – Eastman Chemical Company (NYSE:EMN) announced its fourth-quarter and full-year 2025 financial results.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Generated cash from operating activities approaching $1 billion in 2025, demonstrating the strength of our cash flow and resolve to deliver on our commitments in a difficult environment.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Exhibited commercial excellence in 2025, defending the value of our products in a weak economic environment.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Exceeded cost reduction goals, with aggressive actions that achieved approximately $100 million in savings versus our target of greater than $75 million.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Achieved Kingsport methanolysis facility operational goals, producing greater than 2.5 times production quantities and delivered approximately $60 million of incremental earnings in 2025 versus 2024.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Raised dividend for the 16*<sup>th</sup> *consecutive year and returned approximately $500 million to stockholders in 2025 through dividends and share repurchases.*

---

| | | | | |
|:---|:---|:---|:---|:---|
| (In millions, except per share amounts; unaudited) | **4Q2025** | **4Q2024** | **FY25** | **FY24** |
| Sales revenue | $1973 | $2245 | $8752 | $9382 |
| Earnings before interest and taxes ("EBIT") | 64 | 349 | 776 | 1278 |
| Adjusted EBIT\* | 134 | 305 | 930 | 1298 |
| Earnings per diluted share | 0.92 | 2.82 | 4.10 | 7.67 |
| Adjusted earnings per diluted share\* | 0.75 | 1.87 | 5.42 | 7.89 |
| Net cash provided by operating activities | 502 | 540 | 970 | 1287 |

---

**\*For non-core items excluded from adjusted earnings and for adjusted provision for income taxes, segment adjusted EBIT margins, and net debt, reconciliations to reported company and segment earnings and total borrowings for all periods presented in this release, see Tables <u>[3A](#i6ba10af847b446119f6156ad5b8af828_25)</u>, <u>[3B](#i6ba10af847b446119f6156ad5b8af828_31)</u>, <u>[4](#i6ba10af847b446119f6156ad5b8af828_37)</u>, and <u>[6](#i6ba10af847b446119f6156ad5b8af828_49)</u>.**

"Despite a challenging operating environment for the chemical industry and continued weakness in consumer discretionary end markets, our team delivered a year that demonstrates the strength of our portfolio's ability to generate cash," said Mark Costa, Board Chair and CEO. "In 2025, we generated operating cash flow approaching $1 billion, a clear validation of our disciplined approach to cost and working capital management. Our commercial teams showed excellence in defending the value of our products, and we accelerated our structural cost reductions throughout the year to protect margins and preserve competitiveness. We continued to prioritize stockholder returns and raised the dividend for the 16th consecutive year. In total, we returned approximately $500 million through dividends and share repurchases. We also advanced our strategic growth initiatives, including achieving our Kingsport methanolysis operational goals, producing greater than 2.5 times the recycled content versus 2024 and delivering approximately $60 million of incremental earnings. Looking ahead, we enter 2026 with a diverse portfolio, strong cash-generation capability, and a winning team that is well positioned to drive earnings growth, improve our cost structure, and capture recovery-driven upside when market conditions improve."

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**Corporate Results 4Q 2025 versus 4Q 2024**

Sales revenue decreased 12 percent due to 11 percent lower sales volume/mix and 2 percent lower selling prices partially offset by a favorable foreign currency exchange impact. The lower sales volume/mix was driven by ongoing customer inventory destocking in acetate tow and industry capacity share adjustments as well as higher than usual seasonal demand declines in consumer discretionary end markets. Lower selling prices were driven by weak commodity market fundamentals in Chemical Intermediates.

Adjusted EBIT decreased primarily due to lower sales volume/mix and unfavorable price-cost that was partially offset by the impact of cost reduction initiatives and lower variable compensation expense.

**Segment Results 4Q 2025 versus 4Q 2024**

**Advanced Materials –** Sales revenue decreased 9 percent due to lower sales volume/mix.

Sales volume/mix was lower due to weakness in high-value consumer discretionary end markets and higher than usual seasonal volume declines as customers continued to leverage prepositioned inventory purchased earlier in the year to minimize the impact of tariffs on consumer prices. Prices were unchanged due to commercial excellence in defending price and market share.

EBIT decreased due to lower sales volume/mix and higher raw material cost, partially offset by cost reduction initiatives and lower planned maintenance expense.

**Additives & Functional Products –** Sales revenue decreased 5 percent due to 6 percent lower sales volume/mix.

Lower sales volume/mix was driven by continued weakness in the building and construction and automotive refinish end markets. Stronger volumes in fourth-quarter 2024 were due to order advancement to mitigate the impact of a port strike.

EBIT was lower due to lower sales volume/mix, higher raw material costs, and higher shutdown expense, partially offset by a lower cost structure.

**Fibers –** Sales revenue decreased 27 percent primarily due to lower sales volume/mix.

Lower sales volume/mix was driven by lower acetate tow volume due to ongoing customer inventory destocking relative to last year and industry capacity share adjustments, as well as continued weakness in textile end-market demand due to tariffs.

EBIT declined due to lower sales volume/mix, higher energy and raw material costs, partially offset by cost reduction initiatives.

**Chemical Intermediates –** Sales revenue decreased 17 percent due to 9 percent lower sales volume/mix and 8 percent lower selling prices.

Lower sales volume/mix was primarily due to continued weak demand in the North American building and construction end market and export markets. Lower selling prices were primarily due to increased competitive pressure from Asia.

Adjusted EBIT decreased due to lower spreads resulting from weak end-market demand and heightened competitive activity.

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**Corporate Results 2025 versus 2024**

Sales revenue decreased by 7 percent due to 6 percent lower sales volume/mix and 1 percent lower selling prices.

Lower sales volume/mix was primarily driven by acetate tow inventory destocking and industry capacity share adjustments as well as end-market weakness in most consumer discretionary end markets. Lower selling prices were due to increased competitive activity in Chemical Intermediates.

Adjusted EBIT was lower due to lower sales volume/mix, primarily in Fibers, spread compression in Chemical Intermediates, and lower asset utilization. These factors were partially offset by the impact of cost reduction initiatives, improved operational performance at the Kingsport methanolysis facility, and lower variable compensation expense.

**Segment Results 2025 versus 2024**

**Advanced Materials –** Sales revenue decreased by 6 percent due to 4 percent lower sales volume/mix and 2 percent lower selling prices.

Lower sales volume/mix in advanced interlayers was driven by weakness in the building and construction end market as well as a strategic decision to cede some low-value market share in Europe. Lower sales volume/mix in performance films was driven by weak consumer discretionary spending in the automotive accessories aftermarket. Specialty plastics sales volume/mix was relatively flat, as growth from innovation offset a weak consumer durables market and increased customer caution resulting from tariff uncertainty. Selling prices declined as we shared some raw material tailwinds with customers.

EBIT decreased due to lower sales volume/mix, asset utilization headwinds, and higher energy costs partially offset by lower manufacturing costs both from ramping up the Kingsport methanolysis facility and cost reduction initiatives.

**Additives & Functional Products –** Sales revenue increased by 1 percent due to 3 percent higher selling prices and a favorable foreign currency exchange impact mostly offset by 3 percent lower sales volume/mix.

Selling prices increased primarily due to cost-pass-through contracts adjusting to higher raw material and energy costs. This was offset by lower sales volume primarily due to weakness in the building and construction and automotive refinish end markets, partially offset by growth in stable end markets including water treatment and pharma as well as growth in semiconductors.

EBIT increased primarily due to a lower cost structure partially offset by lower sales volume/mix.

**Fibers –** Sales revenue decreased by 20 percent primarily due to lower sales volume/mix.

Lower sales volume/mix was driven by acetate tow customer inventory destocking and industry capacity share adjustments that persisted throughout the year. Textiles end-market demand also declined mostly due to tariff-related customer demand impacts in Asia and Europe.

EBIT decreased due to lower sales volume/mix, and higher raw material and energy costs, partially offset by cost reduction initiatives.

**Chemical Intermediates –** Sales revenue decreased by 10 percent due to 5 percent lower sales volume/mix and 5 percent lower selling prices.

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

Lower sales volume/mix was primarily due to continued weak demand in North America both from building and construction and durables end markets as well as a mix headwind from increased volume in low value export markets. Lower selling prices were primarily due to increased competitive pressure in Asia.

EBIT decreased primarily due to lower spreads resulting from weak end-market demand and heightened competitive activity.

**Cash Flow** 

In 2025, cash provided by operating activities approached $1 billion compared to approximately $1.3 billion in 2024. The decrease was primarily driven by lower cash earnings. The company returned approximately $500 million to stockholders through dividends and share repurchases. See Table 5. Priorities for uses of available cash in 2026 include payment of the quarterly dividend, capital expenditures, and share repurchases, while maintaining our solid investment-grade balance sheet.

**2026 Outlook**

Commenting on the outlook for full-year 2025, Costa said, "We entered 2026 with momentum on key initiatives to improve our financial results compared to 2025. Given the continued macro uncertainty, which has been a headwind for our industry for over four years, we remain focused on self-help measures that will deliver value this year. First, we are increasing our cost structure reduction actions to a range of $125 million to $150 million, building upon the actions already taken in 2025. Second, we continue to benefit from our innovation model creating growth with the largest driver being our methanolysis facility. Third, we expect improved manufacturing utilization including fewer shutdowns. Given the economic uncertainty and with a focus on driving cash flow, we are expanding our commercial activities into several targeted applications to increase utilization rates. Fourth, we expect a tailwind from foreign currency exchange rates. These factors are expected to be partially offset by headwinds that include variable compensation expense resetting. In addition, we expect lower spreads in Chemical Intermediates and a modest price decline in Fibers to hold volume stable, as well as higher energy costs. When putting these factors together, we are confident we can meaningfully improve earnings compared to 2025. With these assumptions, we also expect operating cash flow to be similar to 2025. At this time, we are not providing a full-year adjusted EPS range due to significant macroeconomic uncertainty. We aim to provide forward-looking commentary when we have more clarity on the macroeconomy.

"When looking at the first quarter, we expect a substantial sequential increase in adjusted EPS. Tailwinds include solid growth in volume/mix from normal seasonality and reduced customer caution after year-end customer inventory management. We also expect lower shutdown costs, improved utilization and continuing cost reduction actions. These tailwinds are expected to be partially offset by modestly lower prices in Fibers and Chemical Intermediates as well as higher energy costs. When putting these factors together, we expect first-quarter adjusted EPS to be between $1.00 and $1.20, excluding the potential impact from the ongoing winter storms."

The first-quarter 2026 projected adjusted diluted EPS excludes any non-core, unusual, or nonrecurring items. Our financial results forecasts do not include non-core items (such as mark-to-market pension and other postretirement benefit gain or loss, and asset impairments and restructuring charges) or any unusual or non-recurring items because we are unable to predict with reasonable certainty the financial impact of such items. These items are uncertain and depend on various factors, and we are unable to reconcile projected adjusted diluted EPS excluding non-core and any unusual or non-recurring items to reported GAAP diluted EPS without unreasonable efforts.

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**Forward-Looking Statements**

The information in this release and other statements by the company may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act (Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). Forward-looking statements are all statements, other than statements of historical fact, that may be made by Eastman Chemical Company from time to time. In some cases, you can identify forward-looking statements by terminology such as "anticipates," "believes," "estimates," "expects," "intends," "may," "plans," "projects," "forecasts," "will," "would," "could," and similar expressions, or expressions of the negative of these terms. Forward-looking statements may relate to, among other items: projections and estimates of earnings, revenues, volumes, pricing, margins, sales, cost reductions, expenses, taxes, liquidity, capital expenditures, cash flow, dividends, share repurchases or other financial items, supply and demand, capacity and utilization, growth opportunities, statements of management's plans, strategies and objectives for future operations, and statements regarding future economic, industry or market conditions or performance. Such projections and estimates are based upon certain preliminary information, internal estimates, and management assumptions, expectations, and plans.

Forward-looking statements and the assumptions underlying them are subject to a number of risks and uncertainties, and actual performance or results could differ materially from expectations expressed in any forward-looking statements if one or more of the underlying assumptions and/or expectations prove to be inaccurate or is unrealized. Forward-looking statements speak only as of the date they are made, and the company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.

Other important assumptions and factors that could cause actual results to differ materially from those in the forward-looking statements are detailed in the sections entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and as updated in the company's filings with the Securities and Exchange Commission (the "SEC"), which are accessible on the SEC's website at www.sec.gov and the company's website at www.eastman.com.

**Financial Measures (Non-GAAP)**

In addition to the financial information presented in accordance with Generally Accepted Accounting Principles ("GAAP"), this press release includes the following non-GAAP financial measures: adjusted EBIT, adjusted EBIT margin, and adjusted earnings per diluted share. We define adjusted EBIT as the GAAP measure EBIT adjusted for non-core, unusual, or non-recurring items. Adjusted earnings per diluted share is defined as the GAAP measure earnings per diluted share adjusted for non-core, unusual, or non-recurring items. Adjusted EBIT margin is defined as adjusted EBIT divided by the GAAP measure sales revenue in the Company's Unaudited Consolidated Statement of Earnings, Comprehensive Income and Retained Earnings for the same periods. Any adjustments described above that are zero for a given period are excluded from the reconciliation tables presented in this release. See the reconciliation tables presented in this release for a detailed reconciliation of non-GAAP financial measures to the most directly comparable GAAP measure.

We believe that in addition to our results determined in accordance with GAAP, these non-GAAP financial measures provide useful information to both management and investors in measuring our financial performance and highlight trends in our business that may not otherwise be apparent when relying solely on GAAP measures. These non-GAAP financial measures provide supplemental information regarding our operating performance that excludes certain gains, losses and non-cash charges that occur relatively infrequently and/or that we consider to be unrelated to our core operations. Non-GAAP financial information is presented for supplemental informational

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

purposes only and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Our presentation of non-GAAP measures should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items. Other companies in our industry may calculate these measures differently, which may limit their usefulness as comparative measures.

**Conference Call and Webcast Information**

Eastman will host a conference call with industry analysts on Jan. 30, 2026, at 8:00 a.m. ET. To listen to the live webcast of the conference call and view the accompanying slides and prepared remarks, go to investors.eastman.com, Events & Presentations. The slides and prepared remarks to be discussed during the call and webcast will be available at investors.eastman.com at approximately 4:15 p.m. ET on Jan. 29, 2026. To listen via telephone, the dial-in number is +1 (833) 470-1428, passcode: 251637. A web replay, a replay in downloadable MP3 format, and the accompanying slides and prepared remarks will be available at investors.eastman.com, Events & Presentations. A telephone replay will be available continuously beginning at approximately 1:00 p.m. Eastern Time, Jan. 31, 2026, through 11:59 p.m. Eastern Time, Feb. 9, 2026, Toll Free at +1 (866) 813-9403, passcode 974396.

Founded in 1920, Eastman is a global specialty materials company that produces a broad range of products found in items people use every day. With the purpose of enhancing the quality of life in a material way, Eastman works with customers to deliver innovative products and solutions while maintaining a commitment to safety and sustainability. The company's innovation-driven growth model takes advantage of world-class technology platforms, deep customer engagement, and differentiated application development to grow its leading positions in attractive end markets such as transportation, building and construction, and consumables. As a globally inclusive company, Eastman employs approximately 13,000 people around the world and serves customers in more than 100 countries. The company had 2025 revenue of approximately $8.8 billion and is headquartered in Kingsport, Tennessee, USA. For more information, visit www.eastman.com.

\# \# \#

Contacts:

Media: Tracy Kilgore Addington

423-224-0498 / tracy@eastman.com

Investors: Greg Riddle

212-835-1620 / griddle@eastman.com

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**FINANCIAL INFORMATION**

**January 29, 2026**

For Eastman Chemical Company Fourth Quarter and Full Year 2025 Financial Results Release

**Table of Contents**

---

| | | |
|:---|:---|:---|
| Item |  | Page |
| <u>[Table 1](#i6ba10af847b446119f6156ad5b8af828_7)</u> | <u>[Statements of Earnings](#i6ba10af847b446119f6156ad5b8af828_7)</u> | <u>[1](#i6ba10af847b446119f6156ad5b8af828_7)</u> |
| <u>[Table 2A](#i6ba10af847b446119f6156ad5b8af828_10)</u> | <u>[Segment Sales Information](#i6ba10af847b446119f6156ad5b8af828_10)</u> | <u>[2](#i6ba10af847b446119f6156ad5b8af828_10)</u> |
| <u>[Table 2B](#i6ba10af847b446119f6156ad5b8af828_16)</u> | <u>[Sales Revenue Change](#i6ba10af847b446119f6156ad5b8af828_16)</u> | <u>[3](#i6ba10af847b446119f6156ad5b8af828_16)</u> |
| <u>[Table 2C](#i6ba10af847b446119f6156ad5b8af828_22)</u> | <u>[Sales by Customer Location](#i6ba10af847b446119f6156ad5b8af828_22)</u> | <u>[3](#i6ba10af847b446119f6156ad5b8af828_22)</u> |
| <u>[Table 3A](#i6ba10af847b446119f6156ad5b8af828_25)</u> | <u>[Segment, Other, and Company Non-GAAP Earnings (Loss) Before Interest and Taxes Reconciliations](#i6ba10af847b446119f6156ad5b8af828_25)</u> | <u>[4](#i6ba10af847b446119f6156ad5b8af828_25)</u> |
| <u>[Table 3B](#i6ba10af847b446119f6156ad5b8af828_31)</u> | <u>[Segment Non-GAAP Earnings (Loss) Before Interest and Taxes Margins](#i6ba10af847b446119f6156ad5b8af828_31)</u> | <u>[7](#i6ba10af847b446119f6156ad5b8af828_31)</u> |
| <u>[Table 4](#i6ba10af847b446119f6156ad5b8af828_37)</u> | <u>[Non-GAAP Earnings Before Interest and Taxes, Net Earnings, and Earnings Per Share Reconciliations](#i6ba10af847b446119f6156ad5b8af828_37)</u> | <u>[8](#i6ba10af847b446119f6156ad5b8af828_37)</u> |
| <u>[Table 5](#i6ba10af847b446119f6156ad5b8af828_46)</u> | <u>[Statements of Cash Flows](#i6ba10af847b446119f6156ad5b8af828_46)</u> | <u>[11](#i6ba10af847b446119f6156ad5b8af828_46)</u> |
| <u>[Table 6](#i6ba10af847b446119f6156ad5b8af828_49)</u> | <u>[Total Borrowings to Net Debt Reconciliations](#i6ba10af847b446119f6156ad5b8af828_49)</u> | <u>[12](#i6ba10af847b446119f6156ad5b8af828_49)</u> |

---

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**Table 1 – Statements of Earnings**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fourth Quarter** | **Fourth Quarter** | **Twelve Months** | **Twelve Months** |
| (Dollars in millions, except per share amounts; unaudited) | **2025** | **2024** | **2025** | **2024** |
| Sales | $1973 | $2245 | $8752 | $9382 |
| Cost of sales <sup>(1)(2)</sup> | 1635 | 1691 | 6908 | 7092 |
| Gross profit | 338 | 554 | 1844 | 2290 |
| Selling, general and administrative expenses | 159 | 182 | 658 | 736 |
| Research and development expenses | 58 | 66 | 255 | 250 |
| Asset impairments, restructuring, and other charges, net | 54 | 10 | 96 | 51 |
| Other components of post-employment (benefit) cost, net | (21) | (58) | (25) | (72) |
| Other (income) charges, net | 24 | 5 | 84 | 47 |
| Earnings before interest and taxes | 64 | 349 | 776 | 1278 |
| Net interest expense | 52 | 52 | 208 | 200 |
| Earnings before income taxes | 12 | 297 | 568 | 1078 |
| Provision for income taxes | (93) | (34) | 93 | 170 |
| &nbsp;&nbsp;&nbsp;Net earnings | 105 | 331 | 475 | 908 |
| &nbsp;&nbsp;&nbsp;Less: Net earnings attributable to noncontrolling interest |  | 1 | 1 | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net earnings attributable to Eastman | $105 | $330 | $474 | $905 |
| Basic earnings per share attributable to Eastman | $0.93 | $2.85 | $4.14 | $7.75 |
| Diluted earnings per share attributable to Eastman | $0.92 | $2.82 | $4.10 | $7.67 |
| Shares (in millions) outstanding at end of period | 114.1 | 115.2 | 114.1 | 115.2 |
| Shares (in millions) used for earnings per share calculation |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 114.0 | 115.6 | 114.7 | 116.7 |
| &nbsp;&nbsp;&nbsp;Diluted | 114.9 | 116.9 | 115.6 | 117.9 |

---

<sup>(1)</sup> Twelve months 2025 includes inventory adjustment charges of $2 million related to the decommissioning of certain assets at performance films facilities in North America.

<sup>(2)</sup> Twelve months 2024 includes inventory adjustment charges of $7 million related to the planned closure of a solvent-based resins production line at an advanced interlayers facility in North America.

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**Table 2A – Segment Sales Information**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fourth Quarter** | **Fourth Quarter** | **Twelve Months** | **Twelve Months** |
| (Dollars in millions, unaudited) | **2025** | **2024** | **2025** | **2024** |
| Sales by Segment |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advanced Materials | $656 | $720 | $2880 | $3050 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additives & Functional Products | 662 | 696 | 2880 | 2862 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical Intermediates | 418 | 503 | 1925 | 2134 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fibers | 234 | 321 | 1050 | 1318 |
| Total Sales by Segment | 1970 | 2240 | 8735 | 9364 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 3 | 5 | 17 | 18 |
| Total Eastman Chemical Company | $1973 | $2245 | $8752 | $9382 |

---

<sup>&nbsp;&nbsp;&nbsp;&nbsp;</sup>

---

| | |
|:---|:---|
| | **Third Quarter** |
| (Dollars in millions, unaudited) | **2025** |
| Sales by Segment |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advanced Materials | $728 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additives & Functional Products | 716 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical Intermediates | 499 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fibers | 254 |
| Total Sales by Segment | 2197 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 5 |
| Total Eastman Chemical Company | $2202 |

---

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**Table 2B – Sales Revenue Change**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fourth Quarter 2025 Compared to Fourth Quarter 2024** | **Fourth Quarter 2025 Compared to Fourth Quarter 2024** | **Fourth Quarter 2025 Compared to Fourth Quarter 2024** | **Fourth Quarter 2025 Compared to Fourth Quarter 2024** |
| | | **Change in Sales Revenue Due To** | **Change in Sales Revenue Due To** | **Change in Sales Revenue Due To** |
| (Unaudited) | **Revenue% Change** | **Volume / Product Mix Effect** | **Price Effect** | **Exchange<br>Rate<br>Effect** |
| Advanced Materials | (9)% | (9)% | (1)% | 1% |
| Additives & Functional Products | (5)% | (6)% | —% | 1% |
| Chemical Intermediates | (17)% | (9)% | (8)% | —% |
| Fibers | (27)% | (26)% | (1)% | —% |
| Total Eastman Chemical Company | (12)% | (11)% | (2)% | 1% |
|  | **Twelve Months 2025 Compared to Twelve Months 2024** | **Twelve Months 2025 Compared to Twelve Months 2024** | **Twelve Months 2025 Compared to Twelve Months 2024** | **Twelve Months 2025 Compared to Twelve Months 2024** |
|  |  | **Change in Sales Revenue Due To** | **Change in Sales Revenue Due To** | **Change in Sales Revenue Due To** |
| (Unaudited) | **Revenue% Change** | **Volume / Product Mix Effect** | **Price Effect** | **Exchange<br>Rate<br>Effect** |
| Advanced Materials | (6)% | (4)% | (2)% | —% |
| Additives & Functional Products | 1% | (3)% | 3% | 1% |
| Chemical Intermediates | (10)% | (5)% | (5)% | —% |
| Fibers | (20)% | (19)% | (1)% | —% |
| Total Eastman Chemical Company | (7)% | (6)% | (1)% | —% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fourth Quarter 2025 Compared to Third Quarter 2025** | **Fourth Quarter 2025 Compared to Third Quarter 2025** | **Fourth Quarter 2025 Compared to Third Quarter 2025** | **Fourth Quarter 2025 Compared to Third Quarter 2025** |
| | | **Change in Sales Revenue Due To** | **Change in Sales Revenue Due To** | **Change in Sales Revenue Due To** |
| (Unaudited) | **Revenue% Change** | **Volume / Product Mix Effect** | **Price Effect** | **Exchange<br>Rate<br>Effect** |
| Advanced Materials | (10)% | (10)% | —% | —% |
| Additives & Functional Products | (8)% | (6)% | (2)% | —% |
| Chemical Intermediates | (16)% | (12)% | (4)% | —% |
| Fibers | (8)% | (7)% | (1)% | —% |
| Total Eastman Chemical Company | (10)% | (9)% | (1)% | —% |

---

**Table 2C – Sales by Customer Location**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fourth Quarter** | **Fourth Quarter** | **Twelve Months** | **Twelve Months** |
| (Dollars in millions, unaudited) | **2025** | **2024** | **2025** | **2024** |
| Sales by Customer Location |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;United States and Canada | $863 | $942 | $3818 | $3937 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Europe, Middle East, and Africa | 521 | 622 | 2304 | 2571 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Asia Pacific | 481 | 556 | 2137 | 2363 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Latin America | 108 | 125 | 493 | 511 |
| Total Eastman Chemical Company | $1973 | $2245 | $8752 | $9382 |

---

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**Table 3A - Segment, Other, and Company**

**Non-GAAP Earnings (Loss) Before Interest and Taxes Reconciliations** <sup>(1)</sup>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fourth Quarter** | **Fourth Quarter** | **Twelve Months** | **Twelve Months** |
| (Dollars in millions, unaudited) | **2025** | **2024** | **2025** | **2024** |
| &nbsp;&nbsp;&nbsp;Advanced Materials |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings before interest and taxes | $41 | $107 | $319 | $442 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales impact from restructuring activities <sup>(2)</sup> |  |  | 2 | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset impairments, restructuring, and other charges, net <sup>(2)(3)</sup> | 18 |  | 28 | 18 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Excluding non-core items | 59 | 107 | 349 | 464 |
| &nbsp;&nbsp;&nbsp;Additives & Functional Products |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings before interest and taxes | 94 | 128 | 512 | 487 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales impact from restructuring activities |  |  |  | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset impairments, restructuring, and other charges, net <sup>(4)</sup> |  |  | 4 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Excluding non-core items | 94 | 128 | 516 | 490 |
| &nbsp;&nbsp;&nbsp;Chemical Intermediates |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings (loss) before interest and taxes | (50) | 20 | (60) | 101 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset impairments and restructuring, and other charges, net <sup>(3)</sup> | 9 |  | 9 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Environmental and other costs <sup>(5)</sup> | 13 |  | 13 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Excluding non-core items | (28) | 20 | (38) | 101 |
| &nbsp;&nbsp;&nbsp;Fibers |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings before interest and taxes | 47 | 103 | 283 | 454 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset impairments, restructuring, and other charges, net <sup>(6)</sup> | 2 |  | 2 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Excluding non-core items | 49 | 103 | 285 | 454 |
| &nbsp;&nbsp;&nbsp;Other |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss before interest and taxes | (68) | (9) | (278) | (206) |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset impairments, restructuring, and other charges net <sup>(7)</sup> | 25 | 10 | 53 | 33 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mark-to-market pension and other postretirement benefit plans (gain) loss, net | (6) | (54) | (6) | (54) |
| &nbsp;&nbsp;&nbsp;&nbsp;Environmental and other costs <sup>(5)</sup> | 9 |  | 49 | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Excluding non-core items | (40) | (53) | (182) | (211) |
| Total Eastman Chemical Company |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings before interest and taxes | 64 | 349 | 776 | 1278 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales impact from restructuring activities |  |  | 2 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset impairments, restructuring, and other charges, net | 54 | 10 | 96 | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mark-to-market pension and other postretirement benefit plans (gain) loss, net | (6) | (54) | (6) | (54) |
| &nbsp;&nbsp;&nbsp;&nbsp;Environmental and other costs | 22 |  | 62 | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total earnings before interest and taxes excluding non-core items | $134 | $305 | $930 | $1298 |

---

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**Table 3A - Segment, Other, and Company**

**Non-GAAP Earnings (Loss) Before Interest and Taxes Reconciliations (continued)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fourth Quarter** | **Fourth Quarter** | **Twelve Months** | **Twelve Months** |
| (Dollars in millions, unaudited) | **2025** | **2024** | **2025** | **2024** |
| Company Non-GAAP Earnings Before Interest and Taxes Reconciliations by Line Items |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings before interest and taxes | $64 | $349 | $776 | $1278 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales  |  |  | 2 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset impairments, restructuring, and other charges, net | 54 | 10 | 96 | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other components of post-employment (benefit) cost, net | (6) | (54) | (6) | (54) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other (income) charges, net | 22 |  | 62 | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total earnings before interest and taxes excluding non-core items | $134 | $305 | $930 | $1298 |

---

<sup>(1)</sup> See "Management's Discussion and Analysis of Financial Condition and Results of Operations" of the [Annual Report on Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/0000915389/000091538925000012/emn-20241231.htm) for 2024 for description of fourth quarter and full year 2024 non-core items.

<sup>(2)</sup> Full year 2025 included inventory adjustment charges of $2 million, severance charges of $4 million, and restructuring charges of $6 million in the Advanced Materials ("AM") segment, related to the decommissioning of certain assets at performance films facilities in North America.

<sup>(3)</sup> Fourth quarter and full year 2025 included asset impairment charges of $18 million and $9 million in the AM and Chemical Intermediates ("CI") segments, respectively, related to certain terminated capital projects within the performance films and intermediates product lines.

<sup>(4)</sup> Full year 2025 included severance charges of $1 million and restructuring charges of $3 million related to the closure of a heat-transfer fluids production line at a North America specialty fluids and energy facility in the Additives & Functional Products ("AFP") segment.

<sup>(5)</sup> Fourth quarter and full year 2025 included adjustments for discontinued licensing programs in the Asia Pacific region within the CI segment of $13 million and non-cash charges for discontinued investment programs reported in "Other" of $13 million. In addition, full year 2025 included $40 million of environmental and other costs from previously divested or non-operational sites and product lines primarily related to increased chemical costs for groundwater treatment and new and extended remediation costs reported in "Other" to be paid out over 30 years.

(6)Fourth quarter and full year 2025 included a loss on sale related to the 2022 closure of an acetate yarn manufacturing facility in Europe.

<sup>(7)</sup> Fourth quarter and full year 2025 included severance charges of $14 million and $34 million, respectively, related to corporate cost reduction initiatives reported in "Other". Additionally fourth quarter and full year 2025 included profitability improvement initiatives of $5 million and $13 million, respectively, and asset impairment charges of $6 million in both periods.

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**Table 3A - Segment, Other, and Company** 

**Non-GAAP Earnings (Loss) Before Interest and Taxes Reconciliations (continued)** <sup>(1)</sup>

---

| | |
|:---|:---|
| | **Third Quarter** |
| (Dollars in millions, unaudited) | **2025** |
| &nbsp;&nbsp;&nbsp;Advanced Materials |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings before interest and taxes | $41 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales impact from restructuring activities | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset impairments, restructuring, and other charges, net | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Excluding non-core items | 53 |
| &nbsp;&nbsp;&nbsp;Additives & Functional Products |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings before interest and taxes | 128 |
| &nbsp;&nbsp;&nbsp;Chemical Intermediates |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings before interest and taxes | 1 |
| &nbsp;&nbsp;&nbsp;Fibers |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings before interest and taxes | 67 |
| &nbsp;&nbsp;&nbsp;Other |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss before interest and taxes | (49) |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset impairments, restructuring, and other charges net | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Excluding non-core items | (39) |
| Total Eastman Chemical Company |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings before interest and taxes | 188 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales impact from restructuring activities | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset impairments, restructuring, and other charges, net | 20 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total earnings before interest and taxes excluding non-core items | $210 |

---

<sup>(1)</sup> For the description of third quarter 2025 non-core items, see "Management's Discussion and Analysis of Financial Condition and Results of Operations" of the <u>[Quarterly Report on Form 10-Q](https://www.sec.gov/Archives/edgar/data/915389/000091538925000183/0000915389-25-000183-index.htm)</u> for third quarter 2025.

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**Table 3B - Segment Non-GAAP Earnings (Loss) Before Interest and Taxes Margins**<sup>(1)(2)</sup>

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Fourth Quarter** | **Fourth Quarter** | **Fourth Quarter** | **Fourth Quarter** | **Twelve Months** | **Twelve Months** | **Twelve Months** | **Twelve Months** |
| (Dollars in millions, unaudited) | **2025** | **2025** | **2024** | **2024** | **2025** | **2025** | **2024** | **2024** |
|  | **Adjusted EBIT** | **Adjusted EBIT Margin** | **Adjusted EBIT** | **Adjusted EBIT Margin** | **Adjusted EBIT** | **Adjusted EBIT Margin** | **Adjusted EBIT** | **Adjusted EBIT Margin** |
| &nbsp;&nbsp;&nbsp;Advanced Materials | $59 | 9.0% | $107 | 14.9% | $349 | 12.1% | $464 | 15.2% |
| &nbsp;&nbsp;Additives & Functional Products | 94 | 14.2% | 128 | 18.4% | 516 | 17.9% | 490 | 17.1% |
| &nbsp;&nbsp;Chemical Intermediates | (28) | (6.7)% | 20 | 4.0% | (38) | (2.0)% | 101 | 4.7% |
| &nbsp;&nbsp;&nbsp;Fibers | 49 | 20.9% | 103 | 32.1% | 285 | 27.1% | 454 | 34.4% |
| Total segment EBIT excluding non-core items | 174 | 8.8% | 358 | 16.0% | 1112 | 12.7% | 1509 | 16.1% |
| Other | (40) |  | (53) |  | (182) |  | (211) |  |
| Total EBIT excluding non-core items | $134 | 6.8% | $305 | 13.6% | $930 | 10.6% | $1298 | 13.8% |

---

---

| | | |
|:---|:---|:---|
| | **Third Quarter** | **Third Quarter** |
| (Dollars in millions, unaudited) | **2025** | **2025** |
|  | **Adjusted EBIT** | **Adjusted EBIT Margin** |
| &nbsp;&nbsp;&nbsp;Advanced Materials | $53 | 7.3% |
| &nbsp;&nbsp;Additives & Functional Products  | 128 | 17.9% |
| &nbsp;&nbsp;Chemical Intermediates  | 1 | 0.2% |
| &nbsp;&nbsp;&nbsp;Fibers | 67 | 26.4% |
| Total segment EBIT excluding non-core items | 249 | 11.3% |
| &nbsp;&nbsp;Other  | (39) |  |
| Total EBIT excluding non-core items | $210 | 9.5% |

---

<sup>(1)</sup> For identification of excluded non-core items and reconciliations to GAAP EBIT, see <u>[Table 3A](#i6ba10af847b446119f6156ad5b8af828_25)</u>.

<sup>(2)</sup> Adjusted EBIT margin is non-GAAP EBIT divided by GAAP sales. See <u>[Table 2A](#i6ba10af847b446119f6156ad5b8af828_10)</u> for sales.

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**Table 4 – Non-GAAP Earnings Before Interest and Taxes, Net Earnings, and Earnings Per Share Reconciliations**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Fourth Quarter 2025** | **Fourth Quarter 2025** | **Fourth Quarter 2025** | **Fourth Quarter 2025** | **Fourth Quarter 2025** | **Fourth Quarter 2025** |
| | **Earnings Before Interest and Taxes** | **Earnings Before Income Taxes** | **Provision for Income Taxes** | **Effective Income Tax Rate** | **Net Earnings<br> Attributable to Eastman** | **Net Earnings<br> Attributable to Eastman** |
| (Dollars in millions, except per share amounts, unaudited) | **Earnings Before Interest and Taxes** | **Earnings Before Income Taxes** | **Provision for Income Taxes** | **Effective Income Tax Rate** | **After Tax** | **Per Diluted Share** |
| **As reported (GAAP)** | $64 | $12 | $(93) | > (100%) | $105 | $0.92 |
| **Non-Core or Unusual Items:** <sup>(1)</sup> |  |  |  |  |  |  |
| &nbsp;&nbsp;Asset impairments, restructuring, and other charges, net | 54 | 54 | 10 |  | 44 | 0.38 |
| &nbsp;&nbsp;Mark-to-market pension and other postretirement benefit plans (gain) loss, net | (6) | (6) | (3) |  | (3) | (0.03) |
| &nbsp;&nbsp;&nbsp;Environmental and other costs | 22 | 22 | 6 |  | 16 | 0.15 |
| &nbsp;&nbsp;Income tax related items <sup>(2)</sup> |  |  | (11) |  | 11 | 0.08 |
| &nbsp;&nbsp;Interim adjustment to tax provision <sup>(3)</sup> |  |  | 86 |  | (86) | (0.75) |
| Non-GAAP (Excluding non-core and unusual items and with adjusted provision for income taxes) | $134 | $82 | $(5) | (5)% | $87 | $0.75 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Fourth Quarter 2024** | **Fourth Quarter 2024** | **Fourth Quarter 2024** | **Fourth Quarter 2024** | **Fourth Quarter 2024** | **Fourth Quarter 2024** |
| | **Earnings Before Interest and Taxes** | **Earnings Before Income Taxes** | **Provision for Income Taxes** | **Effective Income Tax Rate** | **Net Earnings<br> Attributable to Eastman** | **Net Earnings<br> Attributable to Eastman** |
| (Dollars in millions, except per share amounts, unaudited) | **Earnings Before Interest and Taxes** | **Earnings Before Income Taxes** | **Provision for Income Taxes** | **Effective Income Tax Rate** | **After Tax** | **Per Diluted Share** |
| **As reported (GAAP)** | $349 | $297 | $(34) | (11)% | $330 | $2.82 |
| **Non-Core Items:** <sup>(1)</sup> |  |  |  |  |  |  |
| &nbsp;&nbsp;Asset impairments, restructuring, and other charges, net | 10 | 10 | (1) |  | 11 | 0.09 |
| &nbsp;&nbsp;Mark-to-market pension and other postretirement benefit plans (gain) loss, net | (54) | (54) | (14) |  | (40) | (0.34) |
| &nbsp;&nbsp;Income tax related items <sup>(2)</sup> |  |  | (7) |  | 7 | 0.06 |
| &nbsp;&nbsp;Interim adjustment to tax provision <sup>(3)</sup> |  |  | 89 |  | (89) | (0.76) |
| Non-GAAP (Excluding non-core items and with adjusted provision for income taxes) | $305 | $253 | $33 | 14% | $219 | $1.87 |

---

<sup>(1)</sup> See <u>[Table 3A](#i6ba10af847b446119f6156ad5b8af828_25)</u> for description of fourth quarter 2025 and 2024 non-core items excluded from non-GAAP EBIT. Provision for income taxes for non-core items is calculated using the tax rate for the jurisdiction where the gains are taxable and the expenses are deductible.

<sup>(2)</sup> Fourth quarter 2025 includes benefits related to prior tax law changes and a charge related to a valuation allowance driven by tax law changes and macroeconomic conditions impacting certain deferred tax assets in the U.S. Fourth quarter 2024 includes tax expense associated with a previously divested business.

<sup>(3)</sup> Fourth quarter 2025 and 2024 is a reconciliation of the adjustments made to interim quarters to reflect the previously forecasted full year effective tax rate.

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**Table 4 – Non-GAAP Earnings Before Interest and Taxes, Net Earnings, and Earnings Per Share Reconciliations (continued)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Twelve Months 2025** | **Twelve Months 2025** | **Twelve Months 2025** | **Twelve Months 2025** | **Twelve Months 2025** | **Twelve Months 2025** |
| | **Earnings Before Interest and Taxes** | **Earnings Before Income Taxes** | **Provision for Income Taxes** | **Effective Income Tax Rate** | **Net Earnings <br> Attributable to Eastman** | **Net Earnings <br> Attributable to Eastman** |
| (Dollars in millions, except per share amounts, unaudited) | **Earnings Before Interest and Taxes** | **Earnings Before Income Taxes** | **Provision for Income Taxes** | **Effective Income Tax Rate** | **After Tax** | **Per Diluted Share** |
| **As reported (GAAP)** | $776 | $568 | $93 | 16% | $474 | $4.10 |
| **Non-Core or Unusual Items:** <sup>(1)</sup> |  |  |  |  |  |  |
| &nbsp;&nbsp;Cost of sales impact from restructuring activities | 2 | 2 | 1 |  | 1 | 0.01 |
| &nbsp;&nbsp;Asset impairments, restructuring, and other charges, net | 96 | 96 | 21 |  | 75 | 0.65 |
| &nbsp;&nbsp;Mark-to-market pension and other postretirement benefit plans (gain) loss, net | (6) | (6) | (3) |  | (3) | (0.03) |
| &nbsp;&nbsp;&nbsp;Environmental and other costs | 62 | 62 | 15 |  | 47 | 0.41 |
| &nbsp;&nbsp;Income tax related items <sup>(2)</sup> |  |  | (33) |  | 33 | 0.28 |
| Non-GAAP (Excluding non-core and unusual items and with adjusted provision for income taxes) | $930 | $722 | $94 | 13% | $627 | $5.42 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Twelve Months 2024** | **Twelve Months 2024** | **Twelve Months 2024** | **Twelve Months 2024** | **Twelve Months 2024** | **Twelve Months 2024** |
| | **Earnings Before Interest and Taxes** | **Earnings Before Income Taxes** | **Provision for Income Taxes** | **Effective Income Tax Rate** | **Net Earnings <br> Attributable to Eastman** | **Net Earnings <br> Attributable to Eastman** |
| (Dollars in millions, except per share amounts, unaudited) | **Earnings Before Interest and Taxes** | **Earnings Before Income Taxes** | **Provision for Income Taxes** | **Effective Income Tax Rate** | **After Tax** | **Per Diluted Share** |
| **As reported (GAAP)** | $1278 | $1078 | $170 | 16% | $905 | $7.67 |
| **Non-Core Items:** <sup>(1)</sup> |  |  |  |  |  |  |
| &nbsp;&nbsp;Cost of sales impact from restructuring activities | 7 | 7 | 2 |  | 5 | 0.04 |
| &nbsp;&nbsp;Asset impairments, restructuring, and other charges, net | 51 | 51 | 10 |  | 41 | 0.36 |
| &nbsp;&nbsp;Mark-to-market pension and other postretirement benefit plans (gain) loss, net | (54) | (54) | (14) |  | (40) | (0.34) |
| &nbsp;&nbsp;&nbsp;Environmental and other costs | 16 | 16 | 3 |  | 13 | 0.10 |
| &nbsp;&nbsp;Income tax related items <sup>(2)</sup> |  |  | (7) |  | 7 | 0.06 |
| Non-GAAP (Excluding non-core items and with adjusted provision for income taxes) | $1298 | $1098 | $164 | 15% | $931 | $7.89 |

---

<sup>(1)</sup> See <u>[Table 3A](#i6ba10af847b446119f6156ad5b8af828_25)</u> for description of full year 2025 and 2024 non-core items excluded from non-GAAP EBIT. Provision for income taxes for non-core items is calculated using the tax rate for the jurisdiction where the gains are taxable and the expenses are deductible.

<sup>(2)</sup> Full year 2025 includes benefits related to prior tax law changes and a charge related to a valuation allowance driven by tax law changes and macroeconomic conditions impacting certain deferred tax assets in the U.S. Full year 2024 includes tax expense associated with a previously divested business.

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**Table 4 – Non-GAAP Earnings Before Interest and Taxes, Net Earnings, and Earnings Per Share Reconciliations (continued)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Third Quarter 2025** | **Third Quarter 2025** | **Third Quarter 2025** | **Third Quarter 2025** | **Third Quarter 2025** | **Third Quarter 2025** |
| | **Earnings Before Interest and Taxes** | **Earnings Before Income Taxes** | **Provision for Income Taxes** | **Effective Income Tax Rate** | **Net Earnings<br> Attributable to Eastman** | **Net Earnings<br> Attributable to Eastman** |
| (Dollars in millions, except per share amounts, unaudited) | **Earnings Before Interest and Taxes** | **Earnings Before Income Taxes** | **Provision for Income Taxes** | **Effective Income Tax Rate** | **After Tax** | **Per Diluted Share** |
| **As reported (GAAP)** | $188 | $134 | $87 | 65% | $47 | $0.40 |
| **Non-Core or Unusual Items:** <sup>(1)</sup> |  |  |  |  |  |  |
| &nbsp;&nbsp;Cost of sales impact from restructuring activities | 2 | 2 | 1 |  | 1 | 0.01 |
| &nbsp;&nbsp;Asset impairments, restructuring, and other charges, net | 20 | 20 | 5 |  | 15 | 0.13 |
| &nbsp;&nbsp;Income tax related items <sup>(2)</sup> |  |  | (22) |  | 22 | 0.20 |
| &nbsp;&nbsp;Interim adjustment to tax provision <sup>(3)</sup> |  |  | (47) |  | 47 | 0.40 |
| Non-GAAP (Excluding non-core and unusual items and with adjusted provision for income taxes) | $210 | $156 | $24 | 16% | $132 | $1.14 |

---

<sup>(1)</sup> See <u>[Table 3A](#i6ba10af847b446119f6156ad5b8af828_25)</u> for description of third quarter 2025 non-core items excluded from non-GAAP EBIT. Provision for income

taxes for non-core and unusual items is calculated using the tax rate for the jurisdiction where the gains are taxable and the expenses are deductible.

<sup>(2)</sup> Third quarter 2025 includes a charge related to tax law changes.

<sup>(3)</sup> The adjusted provision for income taxes for third quarter 2025 was calculated applying the then forecasted full year effective tax rate.

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**Table 5 – Statements of Cash Flows**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fourth Quarter** | **Fourth Quarter** | **Twelve Months** | **Twelve Months** |
| (Dollars in millions, unaudited) | **2025** | **2024** | **2025** | **2024** |
| Operating activities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net earnings | $105 | $331 | $475 | $908 |
| Adjustments to reconcile net earnings to net cash used in operating activities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 131 | 129 | 513 | 509 |
| &nbsp;&nbsp;Mark-to-market pension and other postretirement benefit plans gain, net | (6) | (54) | (6) | (54) |
| &nbsp;&nbsp;&nbsp;Asset impairment charges | 33 |  | 33 | 5 |
| &nbsp;&nbsp;&nbsp;Provision for (benefit from) deferred income taxes | 102 | 24 | 141 | (52) |
| Changes in operating assets and liabilities, net of effect of acquisitions and divestitures: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;(Increase) decrease in trade receivables | 192 | 182 | 61 | 28 |
| &nbsp;&nbsp;&nbsp;(Increase) decrease in inventories | (49) | (122) | 24 | (344) |
| &nbsp;&nbsp;&nbsp;Increase (decrease) in trade payables | 199 | 152 | (76) | 188 |
| &nbsp;&nbsp;&nbsp;Pension and other postretirement contributions (in excess of) less than expenses | (32) | (12) | (60) | (51) |
| &nbsp;&nbsp;&nbsp;Variable compensation payments (in excess of) less than expenses | 38 | 55 | (22) | 99 |
| &nbsp;&nbsp;&nbsp;Other items, net | (211) | (145) | (113) | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by operating activities** | 502 | 540 | 970 | 1287 |
| Investing activities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Additions to properties and equipment | (112) | (179) | (546) | (599) |
| &nbsp;&nbsp;Government incentives | 7 | 9 | 21 | 9 |
| &nbsp;&nbsp;&nbsp;Proceeds from sale of businesses | 38 | 38 | 38 | 38 |
| &nbsp;&nbsp;&nbsp;Other items, net | 20 |  | 25 | 18 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash used in investing activities**  | (47) | (132) | (462) | (534) |
| Financing activities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net increase (decrease) in commercial paper and other borrowings | (290) |  |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from borrowings |  |  | 246 | 1237 |
| &nbsp;&nbsp;&nbsp;Repayment of borrowings |  |  | (550) | (1039) |
| &nbsp;&nbsp;&nbsp;Dividends paid to stockholders | (94) | (94) | (381) | (379) |
| &nbsp;&nbsp;&nbsp;Treasury stock purchases |  | (100) | (100) | (300) |
| &nbsp;&nbsp;&nbsp;Other items, net | 2 | 13 | (12) | 27 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash used in financing activities** | (382) | (181) | (797) | (454) |
| Effect of exchange rate changes on cash and cash equivalents | 4 | (12) | 18 | (10) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net change in cash and cash equivalents | 77 | 215 | (271) | 289 |
| Cash and cash equivalents at beginning of period | 489 | 622 | 837 | 548 |
| Cash and cash equivalents at end of period | $566 | $837 | $566 | $837 |

---

------

![eastman_blackx300dpia.jpg](eastman_blackx300dpia.jpg)

**Table 6 – Total Borrowings to Net Debt Reconciliations**

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| (Dollars in millions, unaudited) | **2025** | **2024** |
| Total borrowings | $4787 | $5017 |
| Less: Cash and cash equivalents | 566 | 837 |
| Net debt <sup>(1)</sup> | $4221 | $4180 |

---

<sup>(1)</sup> Includes non-cash increase of $68 million in 2025 and non-cash decrease of $32 million in 2024 resulting from foreign currency exchange rates.